Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66

By Rosas J.E.   Hernandez R.M.   Gascon A.R.   Igartua M.   Guzman F.   Patarroyo M.E.   Pedraz J.L.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4445-4451

Elsevier

Access to resources Recommend Favorite

An efficacy trial of the malaria vaccine SPf66 in Gambian infants-second year of follow-up

By Bojang K.A.   Obaro S.K.   D'Alessandro U.   Bennett S.   Langerock P.   Targett G.A.T.   Greenwood B.M.  

Vaccine, Vol. 16, Iss. 1, 1998-01 ,pp. : 62-67

Elsevier

Access to resources Recommend Favorite

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia

By Valero M.V.   Amador R.   Aponte J.J.   Narvaez A.   Galindo C.   Silva Y.   Rosas J.   Guzman F.   Patarroyo M.E.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1466-1470

Elsevier

Access to resources Recommend Favorite

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

By Kashala O.   Amador R.   Valero M.V.   Moreno A.   Barbosa A.   Nickel B.   Daubenberger C.A.   Guzman F.   Pluschke G.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2263-2277

Elsevier

Access to resources Recommend Favorite

Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

By Rosas J.E.   Pedraz J.L.   Hernandez R.M.   Gascon A.R.   Igartua M.   Guzman F.   Rodrguez R.   Cortes J.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1707-1710

Elsevier

Access to resources Recommend Favorite